| NMR Experiment |
|---|
| Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
|---|
| 1 | 3D HNCA | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 600 |
| 2 | 3D HNCACB | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 600 |
| 3 | 3D HN(COCA)CB | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 600 |
| 4 | 3D HCCH-TOCSY | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 600 |
| 5 | 3D HCCONH-TOCSY | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 600 |
| 6 | 3D-CCONH-TOCSY | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 600 |
| 7 | 3D CCH-TOCSY | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 600 |
| 8 | 2D 1H-13C HSQC aliphatic | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 800 |
| 9 | 2D 1H-13C HSQC aromatic | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 800 |
| 10 | 2D 1H-15N HSQC | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 600 |
| 11 | 2D HBCBCGCDCDHE | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 800 |
| 12 | 2D HBCBCGCDCDHE | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 800 |
| 13 | 3D 1H-13C NOESY | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 800 |
| 14 | 3D 1H-15N NOESY | 1 mM [U-13C; U-15N] Anti-GFP Nanobody | 90% H2O/10% D2O | 167.2 mM | 7.4 | 1 atm | 298 | Agilent DD2 800 |